Sandoz Group AG (OTCMKTS:SDZNY) Short Interest Down 52.6% in February

Sandoz Group AG (OTCMKTS:SDZNY) saw a significant decline in short interest during the month of February. As of February 15th, there was short interest totalling 366,500 shares, a decline of 52.6% from the January 31st total of 773,500 shares. Based on an average daily trading volume, of 95,900 shares, the short-interest ratio is presently 3.8 days.

Wall Street Analysts Forecast Growth

SDZNY has been the topic of a number of recent research reports. BNP Paribas lowered Sandoz Group from a “strong-buy” rating to a “hold” rating in a research note on Monday, December 2nd. UBS Group lowered Sandoz Group from a “strong-buy” rating to a “hold” rating in a research note on Monday, February 3rd.

Sandoz Group Stock Performance

OTCMKTS SDZNY traded down $0.30 on Friday, reaching $43.80. 25,962 shares of the company were exchanged, compared to its average volume of 39,512. Sandoz Group has a fifty-two week low of $27.79 and a fifty-two week high of $49.81. The business’s fifty day moving average price is $45.06 and its 200 day moving average price is $43.93.

Sandoz Group Company Profile

Sandoz Group AG develops, manufactures, and markets generic pharmaceuticals and biosimilars worldwide. The company covers therapeutic areas, including cardiovascular, central nervous system, oncology, infectious diseases, pain and respiratory, diabetes, immunology, endocrinology, hematology, and ophthalmology, as well as bone disease.